2024 Global Cyclospora Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition, epidemiology and etiology are reviewed.
The report is available by section, and can be customized to specific information needs and budget.
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
List of Tables
France
Cyclospora Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
Cyclospora Test Volume and Diagnostics Sales Forecast
By Market Segment
Italy
Cyclospora Test Volume and Diagnostics Sales Forecast
By Market Segment
Japan
Cyclospora Test Volume and Diagnostics Sales Forecast
By Market Segment
Spain
Cyclospora Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
Cyclospora Test Volume and Diagnostics Sales Forecast
By Market Segment
U.S.A.
Cyclospora Test Volume and Diagnostics Sales Forecast
By Market Segment
Contains 191 pages and 7 tables
Companies Profiled
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako